Claim OwnershiptouchPODCAST
Subscribed: 2Played: 32
Subscribe
© Copyright 2020 All rights reserved.
Description
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.
Educating physicians on a fully global scale since 2005!
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Educating physicians on a fully global scale since 2005!
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
513 Episodes
Reverse
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY
In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging targeted strategies to overcome these barriers, and highlight the importance of biomarker testing and managing treatment side effects when shaping second-line options for patients.
Course director
Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA
The clinical expert
Prof. Nicholas Girard, Institut Curie, Paris, France
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from AstraZeneca Ltd.
This medical education is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
add url
touchEXPERT FOCUS for touchONCOLOGY
Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC.
The expert:
Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
touchIN CONVERSATION for touchCARDIOLOGY and touchENDOCRINOLOGY
Listen to two experts as they discuss the diagnosis, treatment and how to support patients with FCS. They cover how to recognize key clinical signs and symptoms, strategies to help manage symptoms, reduce triglyceride levels and prevent complications. They also share key insights from their experience with novel targeted therapies for FCS.
The expert(s)
Professor Antonio Gallo, Sorbonne University Hospital Pitié-Salpêtrière, Paris, France
Dr Vikesh Singh, Johns Hopkins University School of Medicine, Baltimore, MD, USA
This touchPODCAST is for HCPs in the USA and Europe only.
This activity is funded by an independent medical education grant from Arrowhead Pharmaceuticals, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our websites: https://touchcardioime.org/fcs-unmasked/ and https://touchendocrinologyime.org/fcs-unmasked/
touchEXPERT FOCUS for touchHAEMATOLOGY
Prof. Lucia de Franceschi, a leading expert in sickle cell disease, examines the clinical manifestations and burden of the condition, reviews current and emerging treatments and offers guidance on comprehensive lifespan care that addresses complications, quality of life, and disparities, while highlighting the essential role of multidisciplinary support.
The experts
Prof. Lucia de Franceschi, University of Verona, Italy
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals, Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchHAEMATOLOGY.com
touchEXPERT FOCUS for touchENDOCRINOLOGY, touchCARDIO and touchNEUROLOGY
Listen to a series of short expert interviews on timely diagnosis and individualized care for Fabry disease, using genetic and clinical insights. Our faculty discuss strategies to reduce diagnostic delays, identify clinically relevant genetic variants and tailor treatment based on each patient's genotype–phenotype correlations.
The experts
Dr Raphael Schiffmann, Texas Christian University, Fort Worth, TX, USA
Ms Dawn Laney, Emory Genetic Clinical Trials Center, Atlanta, GA, USA
Dr Ozlem Goker-Alpan, Lysosomal Disorders Research and Treatment Center (LDRTC), Fairfax, VA, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Amicus Therapeutics Inc.
This activity is jointly provided by USF Health and touchIME.
For further information visit our websites:
www.touchENDOCRINOLOGY.com www.touchCARDIO.com and www.touchNEUROLOGY.com
touchCASES for touchONCOLOGY
Listen to three experts as they discuss how patient and disease characteristics may inform treatment selection in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). They will discuss the cases of three patients which will cover first-line and second-line treatments as well as key considerations for their treatment plans in their patients' cases.
The experts:
Dr Nabil Saba, Winship Cancer Institute, Emory University, Atlanta, GA, USA
Dr Victoria Villaflor, Chao Family Comprehensive Cancer Center, UCI Health, Orange, CA, USA
This activity is for HCPs in the USA only
This activity is funded by an independent medical education grant from Coherus Biosciences.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/treatment-selection-in-r-m-npc/
touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY
Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care.
The experts
Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands
Dr Francesca Gay, University of Torino, Italy
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our websites: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The faculty discuss optimizing fluidics and ultrasound energy, ophthalmic viscosurgical device selection, and integrating technological advances in phacoemulsification into clinical practice.
The experts:
Dr Ike K Ahmed, Prism Eye Institute, Toronto, ON, Canada; John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA
Dr David F Chang, University of California, San Francisco, CA, USA; Altos Eye Physicians, Los Altos, CA, USA
Dr Jennifer Loh, Loh Ophthalmology Associates, Miami, FL, USA
This touchPODCAST is for HCPs in the USA, Latin America and Canada only.
This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchophthalmologyime.org/phacoemulsification-cataract-surgery/
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and management of patients with Stargardt disease. Prof. Traboulsi shares key clinical characteristics and retinal imaging results indicative of Stargardt disease, discusses the right tools to use to accurately and promptly diagnose the condition, and reviews supportive care strategies to maximize patients’ functional vision and improve their wellbeing.
The expert:
Prof. Elias Traboulsi, Cleveland Clinic, Cleveland, OH, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Alkeus Pharmaceuticals, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchOPHTHALMOLOGY.com
touchTALKS for touchENDOCRINOLOGY
Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discussion covers the clinical features and aetiology of DKA, its impact on people living with diabetes, the underlying metabolic pathways, risk factors, common triggers, and the pillars of management. Prof. Sherr also explores strategies for prevention and early intervention plus the advantages, drawbacks and recent developments in ketone monitoring.
The experts
Prof. Jennifer Sherr, Yale School of Medicine, New Haven, CT, US
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchENDOCRINOLOGY.com
touchCASES for touchRESPIRATORY and touchCARDIO
This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial diagnosis and risk stratification to treatment initiation and escalation.
The experts:
Dr Athénaïs Boucly, University of Paris-Saclay, Le Kremlin-Bicêtre, Paris, France
Prof. Pilar Escribano Subìas, Complutense University of Madrid, Spain
This touchPODCAST is for HCPs outside the UK
This activity is provided by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider
For further information, visit our websites: www.touchRESPIRATORY.com and www.touchCARDIO.com
touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY
Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including recent advances and patient education to support effective use.
The experts:
Dr Eden Miller, Diabetes and Obesity Care, Bend, OR, USA
Dr Ian J Neeland, Case Western Reserve University, and Harrington Heart and Vascular Institute, University Hospitals Cleveland, OH, USA
This activity is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchCARDIO.com and www.touchENDOCRINOLOGY.com
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and rare GI cancers. They also address retesting at progression, management of adverse events, and emerging treatment approaches.
The experts
Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium
Prof. Florian Lordick, University of Leipzig, Leipzig, Germany
This touchPODCAST is for HCPs outside of the UK
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchONCOLOGY.com
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-related adverse events through practical monitoring strategies.
The experts
Prof. Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France
Prof. Nicoletta Colombo, University of Milan-Bicocca, Milan, Italy
Dr Brian Slomovitz, Mount Sinai Medical Center, Miami, FL, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/panel-icis-in-ec/
touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO
Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene silencers, as well as emerging therapies aimed at improving patient outcomes.
The expert:
Dr Chafic Karam, University of Pennsylvania, Philadelphia, PA, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our websites:
https://touchneurology.com/ and https://touchcardio.com/
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY
Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice.
Overview
Data reviews with Prof. Moreau
Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below
Clinical themes
Approved BCMA-directed therapeutic approaches
Practical application of BCMA-directed therapies
Future of treating RRMM: Emerging BCMA-directed therapies and combinations
The internationally renowned multiple myeloma expert faculty
Prof. Philippe Moreau: Nantes, France
Prof. Hermann Einsele: Würzburg, Germany
Dr Paola Neri: Calgary, AB, Canada
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com
touchEXPERT FOCUS for touchDERMATOLOGY
Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey.
The expert:
Prof. Ilona Frieden, University of California, San Francisco, CA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Pierre Fabre Pharmaceuticals, Inc.
This activity is jointly provided by USF Health and touchIME in collaboration with our education partner, Pediatric Dermatology Research Alliance (PeDRA).
For further information visit our website:
https://touchdermaime.org/
touchIN CONVERSATION for touchONCOLOGY
Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities.
The experts
Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy
Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchoncologyime.org/adcs-in-the-treatment-of-mbc/
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.
The experts:
Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany
Prof. Rebecca Dent – National Cancer Center Singapore, Singapore
Prof. Peter Schmid – Barts Cancer Institute, London, UK
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/management-of-tnbc-with-immunotherapy/
touchEXPERT FOCUS for touchRESPIRATORY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
Prof. Jonathan Spicer, McGill University, Montreal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/
Comments
Download from Google Play
Download from App Store
United States